Home > Press > Innovation Management and the Emergence of the Nanobiotechnology Industry
Abstract:
The confluence of nanotechnology and biotechnology is creating opportunities and an emerging industry, nanobiotechnology, with tremendous potential for economic and social value creation. The medical applications of nanobiotechnology are promising, including effectively targeted drug delivery - imagine highly efficacious cancer treatment with few side effects - and real time, minimally invasive diagnostics. But there is little known about the emergence of this industry or of ways to reap the possible benefits.
Now an international research team at MIT, Simon Fraser University and the University of New South Wales has stepped in to study the phenomenon. A groundbreaking study recently published in Nature Nanotechnology (see www.nature.com/nnano/journal/v9/n1/fig_tab/nnano.2013.288_ft.html), examined the emergence and evolution of nanobiotechnology through tracking firms with capabilities in both biotechnology and nanotechnology. More than 500 firms have entered the field worldwide since 1990, and it is expected to soon triple in size from $20 billion to over $60 billion in sales. The team also studied two cases of breakthrough inventions - Doxil® and Zevalin® - both of which are effectively targeted cancer therapeutics (see www.sciencedirect.com/science/article/pii/S0923474813000775)
Innovation, and the growth of new industries, is thought to be more likely when a firm occupies the confluence or convergence of distinct streams of emerging technology. Research progress at the intersection of fields is probably more likely to occur when cross-disciplinary new product development teams are designed by the organization and when routines and processes are designed to support cross-disciplinary learning. A confluence of technologies is characterized both by the bringing together of formerly disparate fields of knowledge, and by the creation of new product markets. When a confluence of technology streams occurs, rich opportunities for experiment and progress may result, suggests Professor James Utterback of MIT.
Strategies that one might suggest as particularly useful for enabling innovation would include importing ideas from broad networks and diverse sources, hiring persons from diverse backgrounds, and creating an environment conducive to deep collaboration. This would include co-location of diverse groups, creating a culture and which encourages vigorous debate and differences in perspective.
####
For more information, please click here
Contacts:
Paul Denning
MIT Sloan School of Management
617-253-0576
Copyright © MIT Sloan School of Management
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||